Brexit: Phased Process for implementing Medicines Regulation in Northern Ireland
Recommendation

17/18 June 2026
Copenhagen, Denmark
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
A video conference of the Ireland/Northern Ireland Specialised Committee was held early November exchanging updates on the implementation of the so called Northern Ireland Protocol. The meeting was co-chaired by officials from the UK Government and the EU Commission. Part of the UK delegation also was a representative from the Northern Ireland Executive.
The Committee noted that "an agreed approach had been reached on a phased process for implementing medicines regulation in Northern Ireland up to 31 December 2021, providing the additional time needed for businesses to prepare in relation to batch testing, importation and Falsified Medicines Directive requirements".
Agreement has also been reached on the process for identifying Northern Ireland traders for VAT purposes; for transit procedures and on the elements of the Electricity Directive.
Source: UK Government Press Release "Ireland/Northern Ireland Specialised Committee 05 November 2020".
Related GMP News
29.05.2026European QP Association Developments January through April 2026
15.04.2026ICH Q9 Training Package updated
01.04.2026New EMA GMP Guidelines in the next three Years
01.04.2026New EMA Guidance: Risk Management for Elemental Impurities in Veterinary Medicinal Products
18.03.2026Sampling in the Focus of the FDA
11.03.2026EU Pharma Package: Final Texts officially published


